If approved in the U.S., IGEA’s products will be marketed under the Orthofix brand.
The IGEA products will strengthen Orthofix’s bone growth portfolio, which includes pulsed electromagnetic field products with treatment options such as low-intensity pulsed ultrasound and capacitive coupling for fracture management.
The partnership also includes new technology applications for joint inflammation, pain and cartilage protection.
The combined portfolios will advance Orthofix’s “treatment solutions for fracture management and complement our pursuit of new indications for managing soft tissue and joint health such as our ongoing rotator cuff repair IDE clinical study,” Jon Serbousek, president and CEO of Orthofix, said in an April 28 news release.
More articles on devices:
Why more spine surgeons are looking to invest in ASCs
‘A game-changer’: One spine surgeon’s experience relocating from Brazil to the U.S.
$33M flagship facility opened by 25-physician orthopedic group
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
